The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis

Prosanto Chaudhury, Jeffrey Barkun, John Marshall, Lena Napolitano, N. N. Baxter, K. J. Brasel, C. J. Brown, P. Chaudhury, T. H. Cogbill, C. S. Cutter, E. Dixon, G. W N Fitzgerald, H. J A Henteleff, A. W. Kirkpatrick, S. Latosinsky, A. MacLean, T. M. Mastracci, R. S. McLeod, Leigh A Neumayer, L. A. NeumayerS. Smith, L. R. Temple, M. E. McKenzie

Research output: Contribution to journalArticle

Abstract

Question: Is the use of intensive insulin therapy compared with conventional therapy (on the basis of Leuven titration protocol) and hydroxyethyl starch (HES) compared with Ringer lactate effective and safe in patients with severe sepsis or septic shock? Design: Randomized open-label controlled trial. Setting: Multicentre (18 aca - demic tertiary hospitals in Germany). Patients: Six hundred patients with a diagnosis of severe sepsis or septic shock. Patients were deemed to be eligible if the onset of the syndrome was less than 24 hours before admission to the intensive care unit (ICU) or less than 24 hours after admission if the condition developed in the ICU. Interventions: Patients were randomly assigned in a 2 × 2 factorial design to receive either conventional (target blood glucose 180°C200 mg/dL; n = 326) or intensive insulin therapy (target blood glucose 80°C100 mg/dL; n = 274) or HES (n = 207) or Ringer lactate (n = 303). Main outcomes: Death from any cause at 28 days and morbidity measured by the mean score on the Sequential Organ Failure Assessment (SOFA) on a scale ranging from 0 to 4 for each of 6 organ systems with an aggregate score of 0°C24 and higher scores indicating more severe organ dysfunction. Results: The mean morning blood glucose level was lower in the intensive therapy group (112 mg/dL [6.2 mmol/L]) than in the conventional therapy group (151 mg/dL [8.4 mmol/L]; p ≤ 0.001). However, at 28 days there were no significant differences between the groups in the rate of death or mean score for organ failure. The rate of severe hypoglycemia (glucose level ≤ 40 mg/dL [2.2 mmol/L]) was higher in the intensive therapy group than in the conventional therapy group (17% v. 4.1%; p ≤ 0.001), as was the rate of serious adverse events (10.9% v. 5.2%, p = 0.010). Hydroxyethyl starch therapy was associated with higher rates of acute renal failure and renal replacement therapy than Ringer lactate. Conclusion: The use of the intensive insulin therapy placed critically ill patients with sepsis at an increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful and its toxicity increased with accumulating doses.

Original languageEnglish (US)
Pages (from-to)513-514
Number of pages2
JournalCanadian Journal of Surgery
Volume52
Issue number6
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Hydroxyethyl Starch Derivatives
Resuscitation
Sepsis
Insulin
Group Psychotherapy
Starch
Organ Dysfunction Scores
Blood Glucose
Septic Shock
Hypoglycemia
Intensive Care Units
Therapeutics
Renal Replacement Therapy
Acute Kidney Injury
Tertiary Care Centers
Critical Illness
Germany
Cause of Death
Morbidity
Glucose

ASJC Scopus subject areas

  • Surgery

Cite this

Chaudhury, P., Barkun, J., Marshall, J., Napolitano, L., Baxter, N. N., Brasel, K. J., ... McKenzie, M. E. (2009). The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis. Canadian Journal of Surgery, 52(6), 513-514.

The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis. / Chaudhury, Prosanto; Barkun, Jeffrey; Marshall, John; Napolitano, Lena; Baxter, N. N.; Brasel, K. J.; Brown, C. J.; Chaudhury, P.; Cogbill, T. H.; Cutter, C. S.; Dixon, E.; Fitzgerald, G. W N; Henteleff, H. J A; Kirkpatrick, A. W.; Latosinsky, S.; MacLean, A.; Mastracci, T. M.; McLeod, R. S.; Neumayer, Leigh A; Neumayer, L. A.; Smith, S.; Temple, L. R.; McKenzie, M. E.

In: Canadian Journal of Surgery, Vol. 52, No. 6, 12.2009, p. 513-514.

Research output: Contribution to journalArticle

Chaudhury, P, Barkun, J, Marshall, J, Napolitano, L, Baxter, NN, Brasel, KJ, Brown, CJ, Chaudhury, P, Cogbill, TH, Cutter, CS, Dixon, E, Fitzgerald, GWN, Henteleff, HJA, Kirkpatrick, AW, Latosinsky, S, MacLean, A, Mastracci, TM, McLeod, RS, Neumayer, LA, Neumayer, LA, Smith, S, Temple, LR & McKenzie, ME 2009, 'The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis', Canadian Journal of Surgery, vol. 52, no. 6, pp. 513-514.
Chaudhury P, Barkun J, Marshall J, Napolitano L, Baxter NN, Brasel KJ et al. The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis. Canadian Journal of Surgery. 2009 Dec;52(6):513-514.
Chaudhury, Prosanto ; Barkun, Jeffrey ; Marshall, John ; Napolitano, Lena ; Baxter, N. N. ; Brasel, K. J. ; Brown, C. J. ; Chaudhury, P. ; Cogbill, T. H. ; Cutter, C. S. ; Dixon, E. ; Fitzgerald, G. W N ; Henteleff, H. J A ; Kirkpatrick, A. W. ; Latosinsky, S. ; MacLean, A. ; Mastracci, T. M. ; McLeod, R. S. ; Neumayer, Leigh A ; Neumayer, L. A. ; Smith, S. ; Temple, L. R. ; McKenzie, M. E. / The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis. In: Canadian Journal of Surgery. 2009 ; Vol. 52, No. 6. pp. 513-514.
@article{2ffab8dc27b2493d821e37d589a71e93,
title = "The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis",
abstract = "Question: Is the use of intensive insulin therapy compared with conventional therapy (on the basis of Leuven titration protocol) and hydroxyethyl starch (HES) compared with Ringer lactate effective and safe in patients with severe sepsis or septic shock? Design: Randomized open-label controlled trial. Setting: Multicentre (18 aca - demic tertiary hospitals in Germany). Patients: Six hundred patients with a diagnosis of severe sepsis or septic shock. Patients were deemed to be eligible if the onset of the syndrome was less than 24 hours before admission to the intensive care unit (ICU) or less than 24 hours after admission if the condition developed in the ICU. Interventions: Patients were randomly assigned in a 2 × 2 factorial design to receive either conventional (target blood glucose 180°C200 mg/dL; n = 326) or intensive insulin therapy (target blood glucose 80°C100 mg/dL; n = 274) or HES (n = 207) or Ringer lactate (n = 303). Main outcomes: Death from any cause at 28 days and morbidity measured by the mean score on the Sequential Organ Failure Assessment (SOFA) on a scale ranging from 0 to 4 for each of 6 organ systems with an aggregate score of 0°C24 and higher scores indicating more severe organ dysfunction. Results: The mean morning blood glucose level was lower in the intensive therapy group (112 mg/dL [6.2 mmol/L]) than in the conventional therapy group (151 mg/dL [8.4 mmol/L]; p ≤ 0.001). However, at 28 days there were no significant differences between the groups in the rate of death or mean score for organ failure. The rate of severe hypoglycemia (glucose level ≤ 40 mg/dL [2.2 mmol/L]) was higher in the intensive therapy group than in the conventional therapy group (17{\%} v. 4.1{\%}; p ≤ 0.001), as was the rate of serious adverse events (10.9{\%} v. 5.2{\%}, p = 0.010). Hydroxyethyl starch therapy was associated with higher rates of acute renal failure and renal replacement therapy than Ringer lactate. Conclusion: The use of the intensive insulin therapy placed critically ill patients with sepsis at an increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful and its toxicity increased with accumulating doses.",
author = "Prosanto Chaudhury and Jeffrey Barkun and John Marshall and Lena Napolitano and Baxter, {N. N.} and Brasel, {K. J.} and Brown, {C. J.} and P. Chaudhury and Cogbill, {T. H.} and Cutter, {C. S.} and E. Dixon and Fitzgerald, {G. W N} and Henteleff, {H. J A} and Kirkpatrick, {A. W.} and S. Latosinsky and A. MacLean and Mastracci, {T. M.} and McLeod, {R. S.} and Neumayer, {Leigh A} and Neumayer, {L. A.} and S. Smith and Temple, {L. R.} and McKenzie, {M. E.}",
year = "2009",
month = "12",
language = "English (US)",
volume = "52",
pages = "513--514",
journal = "Canadian Journal of Surgery",
issn = "0008-428X",
publisher = "Canadian Medical Association",
number = "6",

}

TY - JOUR

T1 - The use of intensive insulin therapy and pentastarch resuscitation in patients with severe sepsis

AU - Chaudhury, Prosanto

AU - Barkun, Jeffrey

AU - Marshall, John

AU - Napolitano, Lena

AU - Baxter, N. N.

AU - Brasel, K. J.

AU - Brown, C. J.

AU - Chaudhury, P.

AU - Cogbill, T. H.

AU - Cutter, C. S.

AU - Dixon, E.

AU - Fitzgerald, G. W N

AU - Henteleff, H. J A

AU - Kirkpatrick, A. W.

AU - Latosinsky, S.

AU - MacLean, A.

AU - Mastracci, T. M.

AU - McLeod, R. S.

AU - Neumayer, Leigh A

AU - Neumayer, L. A.

AU - Smith, S.

AU - Temple, L. R.

AU - McKenzie, M. E.

PY - 2009/12

Y1 - 2009/12

N2 - Question: Is the use of intensive insulin therapy compared with conventional therapy (on the basis of Leuven titration protocol) and hydroxyethyl starch (HES) compared with Ringer lactate effective and safe in patients with severe sepsis or septic shock? Design: Randomized open-label controlled trial. Setting: Multicentre (18 aca - demic tertiary hospitals in Germany). Patients: Six hundred patients with a diagnosis of severe sepsis or septic shock. Patients were deemed to be eligible if the onset of the syndrome was less than 24 hours before admission to the intensive care unit (ICU) or less than 24 hours after admission if the condition developed in the ICU. Interventions: Patients were randomly assigned in a 2 × 2 factorial design to receive either conventional (target blood glucose 180°C200 mg/dL; n = 326) or intensive insulin therapy (target blood glucose 80°C100 mg/dL; n = 274) or HES (n = 207) or Ringer lactate (n = 303). Main outcomes: Death from any cause at 28 days and morbidity measured by the mean score on the Sequential Organ Failure Assessment (SOFA) on a scale ranging from 0 to 4 for each of 6 organ systems with an aggregate score of 0°C24 and higher scores indicating more severe organ dysfunction. Results: The mean morning blood glucose level was lower in the intensive therapy group (112 mg/dL [6.2 mmol/L]) than in the conventional therapy group (151 mg/dL [8.4 mmol/L]; p ≤ 0.001). However, at 28 days there were no significant differences between the groups in the rate of death or mean score for organ failure. The rate of severe hypoglycemia (glucose level ≤ 40 mg/dL [2.2 mmol/L]) was higher in the intensive therapy group than in the conventional therapy group (17% v. 4.1%; p ≤ 0.001), as was the rate of serious adverse events (10.9% v. 5.2%, p = 0.010). Hydroxyethyl starch therapy was associated with higher rates of acute renal failure and renal replacement therapy than Ringer lactate. Conclusion: The use of the intensive insulin therapy placed critically ill patients with sepsis at an increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful and its toxicity increased with accumulating doses.

AB - Question: Is the use of intensive insulin therapy compared with conventional therapy (on the basis of Leuven titration protocol) and hydroxyethyl starch (HES) compared with Ringer lactate effective and safe in patients with severe sepsis or septic shock? Design: Randomized open-label controlled trial. Setting: Multicentre (18 aca - demic tertiary hospitals in Germany). Patients: Six hundred patients with a diagnosis of severe sepsis or septic shock. Patients were deemed to be eligible if the onset of the syndrome was less than 24 hours before admission to the intensive care unit (ICU) or less than 24 hours after admission if the condition developed in the ICU. Interventions: Patients were randomly assigned in a 2 × 2 factorial design to receive either conventional (target blood glucose 180°C200 mg/dL; n = 326) or intensive insulin therapy (target blood glucose 80°C100 mg/dL; n = 274) or HES (n = 207) or Ringer lactate (n = 303). Main outcomes: Death from any cause at 28 days and morbidity measured by the mean score on the Sequential Organ Failure Assessment (SOFA) on a scale ranging from 0 to 4 for each of 6 organ systems with an aggregate score of 0°C24 and higher scores indicating more severe organ dysfunction. Results: The mean morning blood glucose level was lower in the intensive therapy group (112 mg/dL [6.2 mmol/L]) than in the conventional therapy group (151 mg/dL [8.4 mmol/L]; p ≤ 0.001). However, at 28 days there were no significant differences between the groups in the rate of death or mean score for organ failure. The rate of severe hypoglycemia (glucose level ≤ 40 mg/dL [2.2 mmol/L]) was higher in the intensive therapy group than in the conventional therapy group (17% v. 4.1%; p ≤ 0.001), as was the rate of serious adverse events (10.9% v. 5.2%, p = 0.010). Hydroxyethyl starch therapy was associated with higher rates of acute renal failure and renal replacement therapy than Ringer lactate. Conclusion: The use of the intensive insulin therapy placed critically ill patients with sepsis at an increased risk for serious adverse events related to hypoglycemia. As used in this study, HES was harmful and its toxicity increased with accumulating doses.

UR - http://www.scopus.com/inward/record.url?scp=73849123913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73849123913&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:73849123913

VL - 52

SP - 513

EP - 514

JO - Canadian Journal of Surgery

JF - Canadian Journal of Surgery

SN - 0008-428X

IS - 6

ER -